Navigation Links
UN Agencys Checklist on Health Care Error

th Alliance, "Any of those things could kill or harm us, so, this isn't some remote idea that affects people who are patients in other parts of the world that we never hear about day-to-day. They could affect any one of us in this room, and that's really what this program is about, trying to reduce risk for health care everywhere for everyone."

Karen Timmons, president of a U.S. based patient safety organization that works with the WHO says "Worldwide, 1.4 million patients who enter the hospital each year actually end up sicker, because they acquire an infection while being treated for their original illness. In the United States, more people die from medical errors than losing their lives from traffic accidents, breast cancer or HIV/AIDS."

Though mistakes are done by medical professionals in the past simple steps and closer scrutiny can reduce them to quite an extent.


'"/>




Page: 1 2

Related medicine news :

1. UN Agency’s Checklist on Health Care Erro
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. Want a Healthy brew? Have some Tea!
4. Healthcare sector is now a multi billion-dollar industry in India
5. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
6. Health at heights
7. Health Officials Recommend Flu Vaccine
8. Slightly High BP Poses Health Risk
9. Unsatisfactory Grade On Womens Health Issues
10. Iodex goes to SmithKline Beecham consumer Healthcare
11. Healthy Medicine Or Harmful Intoxicant?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Agencys Checklist Health Care Error

Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Dynatronics Receives 180-Day NASDAQ Extension 2Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2NxStage Extends Supply Agreement with B Braun Medical Inc to Include Streamline 28R 29 Technology 47454 1NxStage Extends Supply Agreement with B Braun Medical Inc to Include Streamline 28R 29 Technology 47454 2NxStage Extends Supply Agreement with B Braun Medical Inc to Include Streamline 28R 29 Technology 47454 3AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 1AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 2AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 3Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 1Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 2Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 3Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 4Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 5